5-Fluorouracil-d1
For research use only. We do not sell to patients. 5-Fluorouracil-d1 CAS No. : 90344-84-6 Biological Activity:5-Fluorouracil-d1 (5-FU-d1) is the deuterium labeled 5-Fluorouracil. 5-Fluorouracil (5-FU) is an analogue of uracil…
epigenetics modulation frontier
Master of Bioactive Molecules | Inhibitors, Screening Libraries & Proteins
For research use only. We do not sell to patients. 5-Fluorouracil-d1 CAS No. : 90344-84-6 Biological Activity:5-Fluorouracil-d1 (5-FU-d1) is the deuterium labeled 5-Fluorouracil. 5-Fluorouracil (5-FU) is an analogue of uracil…
For research use only. We do not sell to patients. Lobetyolin CAS No. : 129277-38-9 Biological Activity:Lobetyolin, a bioactive compound, is derived from Codonopsis pilosula. Lobetyolin has anti-inflammatory, anti-oxidative and…
For research use only. We do not sell to patients. Abacavir sulfate CAS No. : 188062-50-2 Biological Activity:Abacavir sulfate (Abacavir Hemisulfate) is a competitive, orally active nucleoside reverse transcriptase inhibitor.…
For research use only. We do not sell to patients. Regorafenib-13C,d3 Biological Activity:Regorafenib-13C,d3 is the 13C- and deuterium labeled Regorafenib. Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor…
For research use only. We do not sell to patients. MDM2-p53-IN-15 Biological Activity:MDM2-p53-IN-15 is a MDM2-p53 inhibitor with an IC50 value of 26.1 nM. MDM2-p53-IN-15 inhibits the proliferation of various…
For research use only. We do not sell to patients. Staurosporine CAS No. : 62996-74-1 Biological Activity:Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of…
For research use only. We do not sell to patients. C188-9 CAS No. : 432001-19-9 Biological Activity:C188-9 (TTI-101) is a STAT3 inhibitor, with a Kd of 4.7 nM. C188-9 inhibits…
For research use only. We do not sell to patients. Topoisomerase I/II inhibitor 3 Biological Activity:Topoisomerase I/II inhibitor 3 (compound 7) is a potent topoisomerase I (Topo I) and II…